During the past decade, Centro Estatal de Oncología de Campeche conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Estatal de Oncología de Campeche" #1 collaborator was "Breast International Group" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Centro Estatal de Oncología de Campeche" are "Breast Cancer" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Centro Estatal de Oncología de Campeche" in a lesser frequency.

Most popular intervention types in "Centro Estatal de Oncología de Campeche" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "5-Fluorouracil" (1 trials), "Carboplatin" (1 trials), "Cyclophosphamide" (1 trials), "Docetaxel" (1 trials) and "Doxorubicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Estatal de Oncología de Campeche" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centro Estatal de Oncología de Campeche". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centro Estatal de Oncología de Campeche, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro Estatal de Oncología de Campeche, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".